Christopher Durant Turner insider trades
Open-market stock purchases and sales by Christopher Durant Turner, Chief Medical Officer at Nuvalent, Inc, from SEC Form 4 filings since Jan 4, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | NUVL Nuvalent, Inc | Bought (not open market) | — |
| Jan 6, 2026 | NUVL Nuvalent, Inc | Sold | $128K |
| Jan 6, 2026 | NUVL Nuvalent, Inc | Sold | $159K |
| Jan 6, 2026 | NUVL Nuvalent, Inc | Sold | $22.1K |
| Jan 5, 2026 | NUVL Nuvalent, Inc | Sold | $83.7K |
| Jan 5, 2026 | NUVL Nuvalent, Inc | Sold | $108K |
| Jan 5, 2026 | NUVL Nuvalent, Inc | Sold | $189K |
| Jan 5, 2026 | NUVL Nuvalent, Inc | Sold | $31.2K |
Companies traded
- NUVL Nuvalent, Inc: 20 sales, last Jan 7, 2026
Get free alerts when Christopher Durant Turner files a new trade →